MD Lash Factor contains a derivative of a prostaglandin cloprostenol. Prostaglandins are prescription only ingredients and as such the product can only be used under medical supervision.
Letters are expected to be dispatched by the sponsor within two working days of the agreed date. Recall notices are expected to appear in daily newspapers on Tuesday 2 September 2008.
Classification system:
Class I defects are potentially life-threatening or could cause a serious risk to health.
Class II defects could cause illness or mistreatment, but are not Class I.
Class III defects may not pose a significant hazard to health, but withdrawal may be initiated for other reasons.
Class I & II recalls are considered to be safety related recalls.
